Clinical trial
Dose Finding Study of Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
NCT01200784 is registered in ClinicalTrials.gov with Medice Arzneimittel Pütter GmbH & Co KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose Finding Study of Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
- Lead sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- July 31, 2011
- Enrollment
- 252 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, hemodialysis, hyperphosphatemia